This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ananth J V, Ban T A, Lehmann H E, Rizvi F (1971) An adverse reaction unit: Results and functions. Am J Psychiatry 127: 1339–1344
Anderman B, Griffith R W (1977) Clozapine-induced agranulocytosis: A situation report up to august 1976. Eur J Clin Pharmacol 11: 199–201
Ayd F J (1961) A survey of drug-induced extrapyramidal reactions. JAMA 175: 1054–1060
Ayd F J (1974) Side effects of depot Fluphenazines. Compr Psychiatry 15: 277–284
Bauer D, Gaertner H J (1983) Wirkungen der Neuroleptika auf die Leberfunktion, das blutbildende System, den Blutdruck und die Temperaturregulation. Pharmacopsychiatry 16: 23–29
Capellà D, Laporte J-R (1989) Antipsychotic drugs. In: Dukes M N G, Beeley L (eds) Side effects of drugs Annual 13. Elsevier Science Publishers, New York, pp 340–349
Capellà D, Laporte J-R (1990) Antipsychotic drugs. In: Dukes M N G, Beeley L (eds) Side effects of drugs Annual 14. Elsevier Science Publishers, New York, pp 45–57
Capellà D, Laporte J-R (1991) Antipsychotic drugs. In: Dukes M N G, Aronson J K (eds) Side effects of drugs Annual 15. Elsevier Science Publishers, New York, pp 43–56
Dencker S J, Ahlfors U G, Bech P, Eigen K, Lingjaerde O (1986) Classification of side effects in psychopharmacology. Pharmacopsychiatry 19: 40–42
Dirschedl P, Grohmann R, Schmidt L G (1991) Extrapyramidalmotorische Störungen unter Haloperidol: Ergebnisse aus der AMÜP-Studie. In: Guggenmoss-Holzmann D (Hrsg) Quantitative Methoden in der Epidemiologie. Berlin, September 1990, procedings Springer: Berlin, Heidelberg, New York, Tokyo, S 183–287
Grohmann R, Rüther E, Sassim N, Schmidt L G (1989 a) Adverse effects of clozapine. Psychopharmacology 99: 101–104
Grohmann R, Schmidt L G, Spieß-Kiefer C, Rüther E (1989b) Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AMÜP program. Psychopharmacology 99: 109–112
Grohmann R, Ströbel C, Rüther E et al. (1993) Adverse psychic reactions to psychotropic drugs - A report form the AMÜP study. Pharmacopsychiatry 26: 84–93
Häfner H (1964) Komplikationen der Behandlung mit Neuroleptika in der Klinik. In: Kranz H, Heinrich K (Hrsg) Begleitwirkungen und Mißerfolge der psychiatrischen Pharmakotherapie. Thieme, Stuttgart, S 83–103
Helmchen H, Hippius H (1967) Depressive Syndrome im Verlauf neuroleptischer Therapie. Nervenarzt 38: 455–458
Hippius H (1960) Therapeutisch unerwünschte Wirkungen der modernen Psychopharmaka, I. Mitteilung: Phenothiazin-Derivate und verwandte Verbindungen. Internist (Berlin) 1: 453–460
Keepers G A, Clappison V J, Casey D E (1983) Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes. Arch Gen Psychiatry 40: 1113–1117
Korczyn A D (1980) The major tranquillizers. In: Dukes M N G (ed) Meyler’s side effects of drugs, 9th ed. Elsevier Science Publishers, New York, pp 76–89
Laporte J-R, Capellà D (1987) Antipsychotic drugs. In: Dukes M N G (ed) Side effects of drugs Annual 11. Elsevier Science Publishers, New York, pp 44–61
Laporte J-R, Capellà D (1988) Antipsychotic drugs. In: Dukes M N G, Beeley L (eds) Side effects of drugs Annual 12. Elsevier Science Publishers, New York, pp 50–55
Levinson D F, Simpson G M, Singh H, Yadalam K, Jain A, Stephanos M J, Silver P (1990) Fluphenazine dose, clinical response, and extrapyramidal symptoms during acute treatment. Arch Gen Psychiatry 47: 761–768
Manos N, Lavrentiadis G, Ckiouzepas J (1986) Evaluation of the need for prophylactic antiparkinson medication in psychotic patients treated with neuroleptics. J Clin Psychiatry 47: 114–116
Meya U, Möller B, Renfordt E, Lobeck H (1981) A case of Perazine-induced enteritis-allergy or pseudo-allergy. Pharmacopsychiatry 14: 172–179
Pisciotta A V (1969) Agranulocytosis induced by certain phenothiazine derivates. JAMA 208: 1862–1868
Putten T van, Marder S R, Mintz J (1990) A controlled dose comparison of Haloperidol in newly admitted schizophrenic patients. Arch Gen Psychiatry 47: 754–758
Shader R I (1975) Fear of side effects and denial of treatment. In: Ayd F J (ed) Rational psychopharmacotherapy and the right to treatment. Ayd Medical Communications, Baltimore, pp 106–117
Simpson G M, Pi E H, Sramek J J Jr (1992) Neuroleptics and antipsychotics. In: Dukes M N G (ed) Meyler’s side effects of drugs, 12th edn. Elsevier Science Publishers, New York, pp 105–121
Singh H, Levinson D F, Simpson G M, Lo E S, Friedman E (1990) Acute dystonia during fixed-dose neuroleptic Treatment. Clin Psychopharmacology 10: 389–396
Sramek J J, Simpson G M, Morrison R L et al. (1986) Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: A prospective study. J Clin Psychiatry 47: 305–309
Swett C (1979) Patterns of drug use in psychiatric inpatient wards. J Clin Psychiatry 40: 464–468
Tornatore F L, Sramek J J, Okya B L, Pi E H (1991) Unerwünschte Wirkungen von Psychopharmaka. Thieme, Stuttgart, New York
Wastl R, Grohmann R, Koch R, Rüther E, Schmidt L G (1988) Leberwertveränderungen unter Neuroleptika und ihre Bewertung. In: Helmchen H, Hippius H, Tölle R (Hrsg) Therapie mit Neuroleptika-Perazin. Thieme, Stuttgart, New York, S 87–90
Winslow R S, Stillner V, Coons D J et al. (1986) Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics. Am J Psychiatry 143: 706–710
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Grohmann, R., Rüther, E. (1994). Neuroleptika. In: Grohmann, R., Rüther, E., Schmidt, L.G. (eds) Unerwünschte Wirkungen von Psychopharmaka. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79126-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-79126-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58209-0
Online ISBN: 978-3-642-79126-0
eBook Packages: Springer Book Archive